High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1). DOI:10.3322/caac.21590
   Web of Science ®Google Scholar
• Waks AG, Winer EP. Breast Cancer Treatment. JAMA. 2019;321(3):316.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768.
   PubMed Web of Science ®Google Scholar
• Prat A, Pineda E, Adamo B, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(Suppl 2):S26–S35.
   PubMedGoogle Scholar
• Huo D, Hu H, Rhie SK, et al. Comparison of breast cancer molecular features and survival by african and European ancestry in the cancer genome atlas. JAMA Oncol. 2017;3(12):1654–1662.
   PubMed Web of Science ®Google Scholar
• Provenzano E, Ulaner GA, Chin S-F. Molecular classification of breast cancer. PET Clin. 2018;13(3):325–338.
   PubMed Web of Science ®Google Scholar
• Hammerl D, Smid M, Timmermans AM, et al. Breast cancer genomics and immuno-oncological markers to guide immune therapies. Semin Cancer Biol. 2018;52(Pt 2):178–188.
   PubMedGoogle Scholar
• Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2). DOI:10.1016/j.gendis.2018.05.001
   Web of Science ®Google Scholar
• Goff SL, Danforth DN. The role of immune cells in breast tissue and immunotherapy for the treatment of breast cancer. Clin Breast Cancer. 2021;21(1):e63–e73.
   PubMed Web of Science ®Google Scholar
• Rajarajan D, Selvarajan S, Charan Raja MR, et al. Genome-wide analysis reveals miR-3184-5p and miR-181c-3p as a critical regulator for adipocytes-associated breast cancer. J Cell Physiol. 2019;234(10):17959–17974.
   PubMed Web of Science ®Google Scholar
• Chu D-T, Phuong TNT, Tien NLB, et al. The effects of adipocytes on the regulation of breast cancer in the tumor microenvironment: an update. Cells. 2019;8(8):857.
   Web of Science ®Google Scholar
• Strating JRPM, Martens GJM. The p24 family and selective transport processes at the ER-Golgi interface. Biol Cell. 2009;101(9):495–509.
   PubMed Web of Science ®Google Scholar
• Aber R, Chan W, Mugisha S, et al. Transmembrane emp24 domain proteins in development and disease. Genet Res (Camb). 2019;101:e14.
   PubMed Web of Science ®Google Scholar
• Yang Y-C, Chien M-H, Lai T-C, et al. Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma. J Biomed Sci. 2021;28(1):29.
   PubMed Web of Science ®Google Scholar
• Goga A, Yagabasan B, Herrmanns K, et al. miR-802 regulates Paneth cell function and enterocyte differentiation in the mouse small intestine. Nat Commun. 2021;12(1):3339.
   PubMed Web of Science ®Google Scholar
• Mishra S, Bernal C, Silvano M, et al. The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases. Oncogene. 2019;38(29):5817–5837.
   PubMed Web of Science ®Google Scholar
• Pau NIB, Zakaria Z, Muhammad R, et al. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract. 2010;206(4):223–228.
   PubMed Web of Science ®Google Scholar
• Chang L-Y, Liu L-YD, Roth DA, et al. The major prognostic features of nuclear receptor NR5A2 in infiltrating ductal breast carcinomas. Int J Genomics. 2015;2015:403576.
   PubMed Web of Science ®Google Scholar
• Lian Z-Q, Wang Q, Li W-P, et al. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels. Int J Oncol. 2012;41(2):629–638.
   PubMed Web of Science ®Google Scholar
• Kuo W-H, Chang -Y-Y, Lai L-C, et al. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas. PLoSOne. 2012;7(9):e45831.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W60.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):eaan2507.
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658.
   PubMed Web of Science ®Google Scholar
• Mizuno H, Kitada K, Nakai K, et al. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2(1):18.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D13.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Liu J-Y, Jiang L, Liu -J-J, et al. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients. Sci Rep. 2018;8(1):11955.
   PubMedGoogle Scholar
• Tsherniak A, Vazquez F, Montgomery PG, et al. Defining a cancer dependency map. Cell. 2017;170(3):564–576.e16.
   PubMed Web of Science ®Google Scholar
• Kaemmerer D, Peter L, Lupp A, et al. Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors. Int J Clin Exp Pathol. 2012;5(3):187–194.
   PubMed Web of Science ®Google Scholar
• Min K-W, Chae SW, Kim D-H, et al. Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer. Oncol Lett. 2015;10(1):121–130.
   PubMed Web of Science ®Google Scholar
• Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805–816.
   PubMed Web of Science ®Google Scholar
• Perez EA, Romond EH, Suman VJ, et al. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. J Clin Oncol. 2014;32(33):3744–3752.
   PubMed Web of Science ®Google Scholar
• Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250(4988):1684–1689.
   PubMed Web of Science ®Google Scholar
• Harris L, Fritsche H, Mennel R, et al. American society of clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25(33):5287–5312.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Yee GC, Somerfield MR, et al. American society of clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007;25(17):2464–2472.
   PubMed Web of Science ®Google Scholar
• Criscitiello C. Tumor-associated antigens in breast cancer. Breast Care (Basel). 2012;7(4):262–266.
   PubMed Web of Science ®Google Scholar
• Melero I, Gaudernack G, Gerritsen W, et al. Therapeutic vaccines for cancer: an overview of clinical trials. Nat Rev Clin Oncol. 2014;11(9):509–524.
   PubMed Web of Science ®Google Scholar
• Muenst S, Schaerli AR, Gao F, et al. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat. 2014;146(1):15–24.
   PubMed Web of Science ®Google Scholar
• Evans AS, Lennemann NJ, Coyne CB. BPIFB3 interacts with ARFGAP1 and TMED9 to regulate non-canonical autophagy and RNA virus infection. J Cell Sci. 2021;134(5). DOI:10.1242/jcs.251835
   PubMed Web of Science ®Google Scholar
• Dvela-Levitt M, Kost-Alimova M, Emani M, et al. Small molecule targets tmed9 and promotes lysosomal degradation to reverse proteinopathy. Cell. 2019;178(3):521–535.e23.
   PubMed Web of Science ®Google Scholar
• Connolly DJ, O’Neill LAJ, McGettrick AF. The GOLD domain-containing protein TMED1 is involved in interleukin-33 signaling. J Biol Chem. 2013;288(8):5616–5623.
   PubMed Web of Science ®Google Scholar
• Fenech EJ, Lari F, Charles PD, et al. Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies modulators of innate immune signalling. Elife. 2020;9. DOI:10.7554/eLife.57306.
   PubMed Web of Science ®Google Scholar
• Zhang HM, Cheung P, Yanagawa B, et al. BNips: a group of pro-apoptotic proteins in the Bcl-2 family. Apoptosis. 2003;8(3):229–236.
   PubMed Web of Science ®Google Scholar
• Nishiwaki Y, Yoshizawa A, Kojima Y, et al. The BH3-only SNARE BNip1 mediates photoreceptor apoptosis in response to vesicular fusion defects. Dev Cell. 2013;25(4):374–387.
   PubMed Web of Science ®Google Scholar
• Nakajima K-I, Hirose H, Taniguchi M, et al. Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J. 2004;23(16):3216–3226.
   PubMed Web of Science ®Google Scholar
• Li FH, Xiang L, Ran L, et al. BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells. Eur Rev Med Pharmacol Sci. 2019;23(4):1397–1407.
   PubMed Web of Science ®Google Scholar
• Choi TG, Nguyen MN, Kim J, et al. Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer. J Pathol. 2018;246(1):115–126.
   PubMed Web of Science ®Google Scholar
• Xie L, Li H, Zhang L, et al. Autophagy-related gene: a novel diagnosis and prognosis marker for kidney renal clear cell carcinoma. Aging (Albany NY). 2020;12(2):1828–1842.
   PubMedGoogle Scholar
• Ma X, Wang J, Zhuang J, et al. P4HB modulates epithelial-mesenchymal transition and the β-catenin/Snail pathway influencing chemoresistance in liver cancer cells. Oncol Lett. 2020;20(1):257–265.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo S, Wu Y, et al. a novel hypoxia target gene related to gastric cancer invasion and metastasis. Biomed Res Int. 2019;2019:9749751.
   PubMed Web of Science ®Google Scholar
• Wu Y, Peng Y, Guan B, et al. P4HB: a novel diagnostic and prognostic biomarker for bladder carcinoma. Oncol Lett. 2021;21(2):95.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang J, Zhang Q, et al. P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling. Mol Med Rep. 2019;19(1):231–237.
   PubMed Web of Science ®Google Scholar
• Yang W, Wu X, Zhou F. Collagen Type X Alpha 1 (COL10A1) contributes to cell proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in breast cancer. Med Sci Monit. 2021;27:e928919.
   PubMed Web of Science ®Google Scholar
• Levy AS, Bernstein JL, Xia JJ, et al. Poly-4-Hydroxybutyric acid mesh compares favorably with acellular dermal matrix in tissue expander-based breast reconstruction. Ann Plast Surg. 2020;85(S1 Suppl 1):S2–S7.
   PubMedGoogle Scholar